Ticker Symbol: HLVX
HilleVax Inc
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001888012
Company Profile
hillevax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. our initial program, hil-214, is a virus-like particle (vlp) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: N/A
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $12.96
Change:
-$0.14
(
-1.07%)
Days Range: $12.38 - $13.48
Beta: 1.10
52wk. High: $23.10
52wk. Low: $10.16
Ytd. Change -22.77%
50 Day Moving Average: $12.81
200 Day Moving Average: $14.46
Shares Outstanding: 48416931
Valuation
Market Cap: 62.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A